Cognitive Analytic Therapy-informed Containment for Self-Harm (CATCH)
1 other identifier
interventional
17
1 country
2
Brief Summary
Non-suicidal self-injury (NSSI) is when somebody engages in self-harm, such as cutting, without meaning to end his or her life. A large number of people engage in NSSI for lots of reasons, for example to cope with emotions. However, currently there are large waiting lists to access psychological therapy through the NHS. Therefore, it is important to research brief therapies so that individuals who engage in NSSI can receive treatment quicker. One potentially helpful therapy suggested is Cognitive Analytic Therapy (CAT), which focuses on patterns in relationships. NSSI can be understood as a way in which people relate to themselves, which suggests that CAT would fit well in terms of understanding and working with these difficulties. This study aims to evaluate a brief two-session CAT therapy for people who engage in NSSI. The project aims to evaluate the feasibility and acceptability of the therapy, using interviews and questionnaires. This means looking at whether participants stick with the therapy, and how they find taking part in the therapy. All participants will meet with a researcher for an initial session to complete baseline questionnaires about their current difficulties, thoughts and feelings. Participants will then be randomly allocated to a condition: either the therapy condition or the treatment-as-usual (TAU) condition. Participants in the therapy condition will receive two therapy sessions, whilst participants in the TAU condition will not receive any therapy sessions. All participants will attend a final session to complete more questionnaires. Participants will be asked to complete online surveys weekly. Some participants will be invited to take part in interviews about their experience of the therapy. All participants will receive a shopping voucher as compensation for their time. Using the data collected from this study, future work can be done to provide better treatment for people who engage in NSSI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2019
CompletedFirst Posted
Study publicly available on registry
February 25, 2019
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedJanuary 6, 2021
January 1, 2021
1.4 years
February 20, 2019
January 5, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Acceptability- attendance rates
We will judge the intervention feasible based on whether \> 70% of those randomised to receive the intervention complete both sessions.
Five weeks
Safety- adverse experiences
Safety will be assessed via an Adverse Effects in Psychotherapy (AEP) self-report measure (Hutton, Byrne \& Morrison, 2017; unpublished). Items rated as greater than "a little" will be classified as notable adverse experiences. Adverse events occurring during the course of the trial (identified through discussion with the participant or clinical team) will also be monitored and recorded. These will include hospitalisation (related to mental health), medically serious self-harm (i.e. requiring medical intervention), and suicidal ideation where a plan and intent are present.
Five weeks
Feasibility - completion rate of assessments
Feasibility will be based upon (i) \> 70% of participants attending the post-therapy follow-up point and (ii) a rate of missing data per outcome measure of \< 25% (this rate of missing data has been used to indicate high risk of bias within systematic reviews; Hutton et al., 2015).
Five weeks
Secondary Outcomes (5)
Non-Suicidal Self-Injury
Five weeks
Self-Compassion Scale (SCS; Neff, 2003).
Five weeks
Depressive symptoms
Five weeks
Self-concept instability
Five weeks
Self-injury urges
Five weeks
Study Arms (2)
Cognitive Analytic Informed Brief Therapy
EXPERIMENTALTreatment As Usual
NO INTERVENTIONInterventions
The brief CAT-informed therapy will take place over two sessions. Session one will last around 90 minutes. In session one, we will discuss with the participant their experience of self-harm and begin to support them to make sense of patterns in their self-harming behaviour. This will be done by thinking about the events that come before or follow self-harm, as well as thoughts and emotions associated with self-harm; it will also be done by thinking about ways that the participant relates to him/herself and other people. By the end of the first session, the researcher and the participant will have collaboratively developed a written diagram which shows patterns in the participant's self-harm. Session two will involve revisiting the mapping of patterns. The researcher and participant will the collaboratively develop 'exits' or ways to break patterns and cycles of thinking, feeling and behaviour. Both sessions will have structured endings.
Eligibility Criteria
You may qualify if:
- Be aged over 16 years (parental consent is not needed; The British Psychological Society, 2008)
- Be comfortable with and have access to email and the internet for completing study measures
- Be currently under or receiving support form clinical/health service including NHS, 3rd sector, or University health services
- Following DSM-V (American Psychiatric Association, 2013), have had five or more instances of NSSI in the past year:
- NSSI methods are operationalised to include cutting, burning, biting, or scratching oneself, as well as head-banging or self-poisoning.
- Have an adequate English language ability to understand study materials
- Be deemed capable of providing informed consent by their clinical team.
You may not qualify if:
- Be currently receiving any other psychological therapy (e.g. including but not limited to CBT and/or DBT), and will not have received psychological therapies in the last one month.
- Have previously received any CAT
- Have been diagnosed with Learning Disability or Autistic Spectrum Disorder as judged by clinical team - since the intervention has not been developed for this population
- Be currently judged at high risk of suicidal behaviour (although if participants were keen to be involved, they could be considered when their mental health has improved).
- Have been hospitalised as a result of self-harm in the past month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mersery Care NHS Foundation Trust
Liverpool, United Kingdom
Greater Manchester Mental Health NHS Foundation Trust
Manchester, United Kingdom
Related Publications (1)
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
PMID: 33884617DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical lecturer
Study Record Dates
First Submitted
February 20, 2019
First Posted
February 25, 2019
Study Start
April 1, 2019
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
January 6, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share
Due to the small scale nature of the trial there is no plan to share Individual Patient Data